منابع مشابه
Treating Dementia with Vitamin B3 and NADH
Dementia affects approximately 5 million people in the United States, and about 475,000 elderly Canadians. Dementia is a debilitating and often progressive illness. The most common type of dementia is Alzheimer’s disease, followed by vascular types. There is a need to investigate novel treatments because the current crop of medications have limited value. Niacin might be a worthwhile treatment ...
متن کاملPerception vs. Reality: Challenge, Control And Mystery In Video Games
Long have studies attempted to bridge the gap between perception and reality for video games attributes. This study highlights the relationship between what a player perceives about certain game attributes (Challenge, Control and Mystery) and how those elements are actually portrayed in the game. We measured user perception with a post-game questionnaire and compared that to the answers of poin...
متن کاملVitamin B3, the nicotinamide adenine dinucleotides and aging.
Organism aging is a process of time and maturation culminating in senescence and death. The molecular details that define and determine aging have been intensely investigated. It has become appreciated that the process is partly an accumulation of random yet inevitable changes, but it can be strongly affected by genes that alter lifespan. In this review, we consider how NAD(+) metabolism plays ...
متن کاملNAD+ and vitamin B3: from metabolism to therapies.
The role of NAD(+) metabolism in health and disease is of increased interest as the use of niacin (nicotinic acid) has emerged as a major therapy for treatment of hyperlipidemias and with the recognition that nicotinamide can protect tissues and NAD(+) metabolism in a variety of disease states, including ischemia/reperfusion. In addition, a growing body of evidence supports the view that NAD(+)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Analytical and Bioanalytical Chemistry
سال: 2018
ISSN: 1618-2642,1618-2650
DOI: 10.1007/s00216-018-1093-8